Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Imunon, Inc. (IMNN : NSDQ)

• Company Description    Imunon Inc. is a fully integrated, clinical stage biotechnology company. It focused on advancing a portfolio of treatments which harness the body's natural mechanisms. The company's lead clinical program includes GEN-1. Imunon Inc., formerly known as Celsion Corporation, is based in LAWRENCEVILLE, N.J. Number of Employees: 20

• Price / Volume Information    Yesterday's Closing Price: $1.24 Daily Weekly Monthly 20 Day Moving Average: 100,660 shares Shares Outstanding: 5.61 (millions) Market Capitalization: $6.93 (millions) Beta: 2.01 52 Week High: $4.93 52 Week Low: $0.96 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -8.52% -7.55% 12 Week -22.81% -24.70% Year To Date -67.59% -70.69%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 997 LENOX DRIVE SUITE 100 - LAWRENCEVILLE,NJ 08648 USA ph: 609-896-9100 fax: 609-896-2200 investorrelations@imunon.com http://www.imunon.com

• General Corporate Information    Officers Stacy Lindborg - President and Chief Executive Officer Michael H. Tardugno - Executive Chairman Jeffrey W. Church - Chief Financial Officer Frederick J. Fritz - Director James E. Dentzer - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 15117N701 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/12/26 Share - Related Items Shares Outstanding: 5.61 Most Recent Split Date: 8.00 (1.15:1) Beta: 2.01 Market Capitalization: $6.93 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.47 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.37 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.68 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 71.12% vs. Previous Quarter: 35.71% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 09/30/26 - - 06/30/26 - -358.01 03/31/26 - -341.23 ROA 09/30/26 - - 06/30/26 - -132.91 03/31/26 - -153.79 Current Ratio 09/30/26 - - 06/30/26 - 1.82 03/31/26 - 1.59 Quick Ratio 09/30/26 - - 06/30/26 - 1.82 03/31/26 - 1.59 Operating Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Net Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Pre-Tax Margin 09/30/26 - - 06/30/26 - - 03/31/26 - - Book Value 09/30/26 - - 06/30/26 - 0.46 03/31/26 - 0.84 Inventory Turnover 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Equity 09/30/26 - - 06/30/26 - 2.86 03/31/26 - 0.00 Debt-to-Capital 09/30/26 - - 06/30/26 - 56.92 03/31/26 - 0.00

Powered by Zacks Investment Research ©